Markus Warmuth - Net Worth and Insider Trading

Markus Warmuth Net Worth

The estimated net worth of Markus Warmuth is at least $8 Million dollars as of 2026-09-11. Markus Warmuth is the President & CEO of Monte Rosa Therapeutics Inc and owns about 585,038 shares of Monte Rosa Therapeutics Inc (GLUE) stock worth over $8 Million. Details can be seen in Markus Warmuth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Markus Warmuth has not made any transactions after 2026-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Markus Warmuth

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Markus Warmuth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Markus Warmuth owns 1 companies in total, including Monte Rosa Therapeutics Inc (GLUE) .

Click here to see the complete history of Markus Warmuth’s form 4 insider trades.

Insider Ownership Summary of Markus Warmuth

Ticker Company Transaction Date Type of Owner
GLUE Monte Rosa Therapeutics Inc 2026-07-16 director & See Remarks

Markus Warmuth Latest Holdings Summary

Markus Warmuth currently owns a total of 1 stock. Markus Warmuth owns 585,038 shares of Monte Rosa Therapeutics Inc (GLUE) as of July 16, 2026, with a value of $8 Million.

Latest Holdings of Markus Warmuth

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GLUE Monte Rosa Therapeutics Inc 2026-07-16 585,038 14.32 8,377,744

Holding Weightings of Markus Warmuth


Markus Warmuth Form 4 Trading Tracker

According to the SEC Form 4 filings, Markus Warmuth has made a total of 7 transactions in Monte Rosa Therapeutics Inc (GLUE) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Monte Rosa Therapeutics Inc is the sale of 9,500 shares on July 16, 2026, which brought Markus Warmuth around $220,210.

Insider Trading History of Markus Warmuth

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Markus Warmuth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Markus Warmuth owns.
View GLUE Analysis

Markus Warmuth Ownership Network

Ownership Network List of Markus Warmuth

No Data

Ownership Network Relation of Markus Warmuth

Insider Network Chart


Markus Warmuth Owned Company Details

What does Monte Rosa Therapeutics Inc do?

Who are the key executives at Monte Rosa Therapeutics Inc?

Markus Warmuth is the director & See Remarks of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include Chief Operating Officer Jennifer Champoux , Chief Technology Officer Sharon Townson , and Chief Medical Officer Filip Janku .

Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary

Over the past 18 months, Markus Warmuth made 7 insider transaction in Monte Rosa Therapeutics Inc (GLUE) with a net sale of 49,500. Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 15,682 shares made by Jennifer Champoux , a net sale of 65,596 shares made by Filip Janku , and a net sale of 21,155 shares made by Sharon Townson .

In summary, during the past 3 months, insiders sold 93,454 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 93,454 shares. During the past 18 months, 209,873 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 199,873 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Monte Rosa Therapeutics Inc Insider Transactions

No Available Data

Markus Warmuth Mailing Address

Above is the net worth, insider trading, and ownership report for Markus Warmuth. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Markus Warmuth's mailing address is: Boston Ma 02135.